Calcitonin gene-related peptide: physiology and pathophysiology

Area of Science:

• Biochemistry
• Neuroscience
• Pharmacology

Background:

• Calcitonin gene-related peptide (CGRP) is a 37-amino acid neuropeptide derived from alternative RNA processing of the calcitonin gene.
• CGRP exists in two forms (α and β) and acts via a receptor complex involving calcitonin receptor-like receptor (CLR) and receptor activity modifying protein (RAMP).

Purpose of the Study:

• To review the known biological functions of CGRP, particularly its role in cardiovascular physiology and pain pathways.
• To discuss the therapeutic potential of CGRP antagonists, with a focus on migraine treatment and emerging research in other conditions.

Main Methods:

• Literature review and synthesis of existing research on CGRP.
• Discussion of drug development based on CGRP antagonism.

Main Results:

• CGRP is a potent vasodilator with protective roles in cardiovascular conditions and wound healing.
• CGRP is implicated in pain pathways, and antagonists have shown efficacy in alleviating migraine.
• Limited information exists regarding CGRP's role in arthritis, skin conditions, diabetes, and obesity.

Conclusions:

• CGRP is a significant peptide in mammalian biology with established roles in vasodilation and pain.
• CGRP antagonists represent a promising therapeutic avenue, particularly for migraine.
• Further research is needed to fully elucidate CGRP's potential in treating various diseases.